XTLB
XTL Biopharmaceuticals Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.53
+1.20%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.04x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.17x
- Net debt / EBITDA
- 0.29x
Liquidity & coverage
- Current ratio
- 0.61x
- Quick ratio
- 0.61x
- Cash ratio
- 0.52x
- Interest coverage
- -25.26x
- EBITDA / interest
- -9.20x
- Working capital
- -$867.0K
Cash & dividend
- FCF / debt
- 0.00x
- Cash flow / debt
- 0.00x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025